ALK c.1438_1439delinsGC ;(p.C480A)

Variant ID: 2-29543724-CA-GC

NM_004304.4(ALK):c.1438_1439delinsGC;(p.C480A)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.

Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Azad, Taha T; Singaravelu, Ragunath R; Taha, Zaid Z; Jamieson, Taylor R TR; Boulton, Stephen S; Crupi, Mathieu J F MJF; Martin, Nikolas T NT; Brown, Emily E F EEF; Poutou, Joanna J; Ghahremani, Mina M; Pelin, Adrian A; Nouri, Kazem K; Rezaei, Reza R; Marshall, Christopher Boyd CB; Enomoto, Masahiro M; Arulanandam, Rozanne R; Alluqmani, Nouf N; Samson, Reuben R; Gingras, Anne-Claude AC; Cameron, D William DW; Greer, Peter A PA; Ilkow, Carolina S CS; Diallo, Jean-Simon JS; Bell, John C JC
Publication Date: 2021-06-02

Variant appearance in text: ALK: C480A
PubMed Link: 33578036
Variant Present in the following documents:
  • mmc3.pdf
  • main.pdf
View BVdb publication page